Philippe J Guerin

Author PubWeight™ 100.36‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Spread of artemisinin resistance in Plasmodium falciparum malaria. N Engl J Med 2014 11.87
2 Scaling up of highly active antiretroviral therapy in a rural district of Malawi: an effectiveness assessment. Lancet 2006 10.91
3 Standardizing the measurement of parasite clearance in falciparum malaria: the parasite clearance estimator. Malar J 2011 5.65
4 The threat of artemisinin-resistant malaria. N Engl J Med 2011 4.15
5 Effectiveness of mass oral cholera vaccination in Beira, Mozambique. N Engl J Med 2005 3.68
6 Effect of preventive supplementation with ready-to-use therapeutic food on the nutritional status, mortality, and morbidity of children aged 6 to 60 months in Niger: a cluster randomized trial. JAMA 2009 3.48
7 The dynamics of measles in sub-Saharan Africa. Nature 2008 3.35
8 Operational response to malaria epidemics: are rapid diagnostic tests cost-effective? Trop Med Int Health 2006 2.39
9 Efficacy and safety of artemether-lumefantrine compared with quinine in pregnant women with uncomplicated Plasmodium falciparum malaria: an open-label, randomised, non-inferiority trial. Lancet Infect Dis 2010 2.24
10 Treatment options for visceral leishmaniasis: a systematic review of clinical studies done in India, 1980-2004. Lancet Infect Dis 2005 2.06
11 The primacy of public health considerations in defining poor quality medicines. PLoS Med 2011 1.91
12 Evaluation of three parasite lactate dehydrogenase-based rapid diagnostic tests for the diagnosis of falciparum and vivax malaria. Malar J 2009 1.86
13 Mind the gaps--the epidemiology of poor-quality anti-malarials in the malarious world--analysis of the WorldWide Antimalarial Resistance Network database. Malar J 2014 1.86
14 Poor quality vital anti-malarials in Africa - an urgent neglected public health priority. Malar J 2011 1.76
15 Meningitis serogroup W135 outbreak, Burkina Faso, 2002. Emerg Infect Dis 2007 1.75
16 Mapping the aetiology of non-malarial febrile illness in Southeast Asia through a systematic review--terra incognita impairing treatment policies. PLoS One 2012 1.56
17 World Antimalarial Resistance Network I: clinical efficacy of antimalarial drugs. Malar J 2007 1.56
18 Late vaccination reinforcement during a measles epidemic in Niamey, Niger (2003-2004). Vaccine 2006 1.53
19 Mitigating the threat of artemisinin resistance in Africa: improvement of drug-resistance surveillance and response systems. Lancet Infect Dis 2012 1.53
20 Bleach sedimentation: an opportunity to optimize smear microscopy for tuberculosis diagnosis in settings of high prevalence of HIV. Clin Infect Dis 2008 1.38
21 Research in complex humanitarian emergencies: the Médecins Sans Frontières/Epicentre experience. PLoS Med 2008 1.20
22 High-throughput analysis of antimalarial susceptibility data by the WorldWide Antimalarial Resistance Network (WWARN) in vitro analysis and reporting tool. Antimicrob Agents Chemother 2013 1.15
23 Prevalence study of yaws in the Democratic Republic of Congo using the lot quality assurance sampling method. PLoS One 2009 1.14
24 Early parasitological response following artemisinin-containing regimens: a critical review of the literature. Malar J 2013 1.14
25 Implementation of a reference standard and proficiency testing programme by the World Wide Antimalarial Resistance Network (WWARN). Malar J 2010 1.11
26 Spatiotemporal mathematical modelling of mutations of the dhps gene in African Plasmodium falciparum. Malar J 2013 1.11
27 Mortality risk among children admitted in a large-scale nutritional program in Niger, 2006. PLoS One 2009 1.07
28 Efficacy of fixed-dose combination artesunate-amodiaquine versus artemether-lumefantrine for uncomplicated childhood Plasmodium falciparum malaria in Democratic Republic of Congo: a randomized non-inferiority trial. Malar J 2012 1.07
29 Reducing wasting in young children with preventive supplementation: a cohort study in Niger. Pediatrics 2010 1.04
30 Burden of disease and circulating serotypes of rotavirus infection in sub-Saharan Africa: systematic review and meta-analysis. Lancet Infect Dis 2009 1.04
31 Effectiveness of ready-to-use therapeutic food compared to a corn/soy-blend-based pre-mix for the treatment of childhood moderate acute malnutrition in Niger. J Trop Pediatr 2010 1.04
32 Performance of a histidine-rich protein 2 rapid diagnostic test, Paracheck Pf®, for detection of malaria infections in Ugandan pregnant women. Am J Trop Med Hyg 2012 1.03
33 Evaluation of a rapid test for the diagnosis of cholera in the absence of a gold standard. PLoS One 2012 1.02
34 Population pharmacokinetics of Artemether and dihydroartemisinin in pregnant women with uncomplicated Plasmodium falciparum malaria in Uganda. Malar J 2012 1.00
35 Clinical determinants of early parasitological response to ACTs in African patients with uncomplicated falciparum malaria: a literature review and meta-analysis of individual patient data. BMC Med 2015 0.99
36 Trends in antimalarial drug use in Africa. Am J Trop Med Hyg 2013 0.99
37 The effect of dosing strategies on the therapeutic efficacy of artesunate-amodiaquine for uncomplicated malaria: a meta-analysis of individual patient data. BMC Med 2015 0.99
38 Assessing antimalarial efficacy in a time of change to artemisinin-based combination therapies: the role of Médecins Sans Frontières. PLoS Med 2008 0.98
39 Transmission of Plasmodium vivax in south-western Uganda: report of three cases in pregnant women. PLoS One 2011 0.97
40 Infections in children admitted with complicated severe acute malnutrition in Niger. PLoS One 2013 0.95
41 Evaluation of combined LED-fluorescence microscopy and bleach sedimentation for diagnosis of tuberculosis at peripheral health service level. PLoS One 2011 0.94
42 Pharyngeal carriage of Neisseria meningitidis in 2-19-year-old individuals in Uganda. Trans R Soc Trop Med Hyg 2006 0.93
43 Meningitis dipstick rapid test: evaluating diagnostic performance during an urban Neisseria meningitidis serogroup A outbreak, Burkina Faso, 2007. PLoS One 2010 0.93
44 Prevalence, risk factors, and impact on outcome of cytomegalovirus replication in serum of Cambodian HIV-infected patients (2004-2007). J Acquir Immune Defic Syndr 2009 0.90
45 Artemether-lumefantrine to treat malaria in pregnancy is associated with reduced placental haemozoin deposition compared to quinine in a randomized controlled trial. Malar J 2012 0.90
46 Estimation of malaria haplotype and genotype frequencies: a statistical approach to overcome the challenge associated with multiclonal infections. Malar J 2014 0.89
47 Emergence of new Salmonella Enteritidis phage types in Europe? Surveillance of infections in returning travellers. BMC Med 2004 0.89
48 Monitoring antimalarial resistance: launching a cooperative effort. Trends Parasitol 2010 0.89
49 Clonal reconquest of antibiotic-susceptible Salmonella enterica serotype Typhi in Son La Province, Vietnam. Am J Trop Med Hyg 2007 0.88
50 Field evaluation of two rapid diagnostic tests for Neisseria meningitidis serogroup A during the 2006 outbreak in Niger. PLoS One 2009 0.88
51 Prevalence and risk factors of Lassa seropositivity in inhabitants of the forest region of Guinea: a cross-sectional study. PLoS Negl Trop Dis 2009 0.87
52 Pharmacokinetic properties of artemether, dihydroartemisinin, lumefantrine, and quinine in pregnant women with uncomplicated plasmodium falciparum malaria in Uganda. Antimicrob Agents Chemother 2013 0.86
53 Use of filter paper as a transport medium for laboratory diagnosis of cholera under field conditions. J Clin Microbiol 2011 0.81
54 Treatment of severe malnutrition with 2-day intramuscular ceftriaxone vs 5-day amoxicillin. Ann Trop Paediatr 2008 0.81
55 A look back at an ongoing problem: Shigella dysenteriae type 1 epidemics in refugee settings in Central Africa (1993-1995). PLoS One 2009 0.78
56 Gastro-enteritis outbreak among Nordic patients with psoriasis in a health centre in Gran Canaria, Spain: a cohort study. BMC Infect Dis 2004 0.75
57 International health research monitoring: exploring a scientific and a cooperative approach using participatory action research. BMJ Open 2014 0.75
58 [Drugs against the neglected diseases]. Tidsskr Nor Laegeforen 2002 0.75